Disposition pursuant to a tender of shares in a change of control transaction by Gordon Carl L of Theseus Pharmaceuticals

THRXDelisted Stock  USD 3.71  0.14  3.92%   
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
  
Filed transaction by Theseus Pharmaceuticals I director. Disposition pursuant to a tender of shares in a change of control transaction

Read at finance.yahoo.com
Yahoo News
  
Theseus insider trading alert for disposition of common stock by Gordon Carl L, the corporate stakeholder, on 14th of February 2024. This event was filed by Theseus Pharmaceuticals I with SEC on 2024-02-14. Statement of changes in beneficial ownership - SEC Form 4

Theseus Pharmaceuticals Fundamental Analysis

We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

Theseus Pharmaceuticals is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

Theseus Pharmaceuticals Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.

Peers

Theseus Pharmaceuticals Related Equities

MRSNMersana Therapeutics   8.47   
0%
78.0%
TERNTerns Pharmaceuticals   7.18   
0%
66.0%
RCUSArcus Biosciences   2.84   
0%
26.0%
ERASErasca   2.17   
0%
20.0%
ELVNEnliven Therapeutics   1.97   
0%
18.0%
GLUEMonte Rosa   1.86   
0%
17.0%
IMRXImmuneering Corp   1.57   
0%
14.0%
PMVPPmv Pharmaceuticals   1.42   
0%
13.0%
HOOKHookipa Pharma   0.50   
0%
4.0%
BPMCBlueprint Medicines   0.99   
9.0%
0%
RLAYRelay Therapeutics   1.54   
14.0%
0%
DSGNDesign Therapeutics   2.63   
24.0%
0%
CGEMCullinan Oncology   2.91   
26.0%
0%
IPSCCentury Therapeutics   3.53   
32.0%
0%
DAWNDay One   3.69   
34.0%
0%
XFORX4 Pharmaceuticals   10.81   
100.0%
0%
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Consideration for investing in Theseus Stock

If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Stocks Directory
Find actively traded stocks across global markets